Osteoblastic response in patients with non-small cell lung cancer with activating EGFR Mutations and bone metastases during treatment with EGFR kinase inhibitors

Ansén S, Bangard C, Querings S, Gabler F, Scheffler M, Seidel D, Saal B, Zander T, Nogová L, Töpelt K, Markert E, Stoelben E, Ernestus K, Thomas RK, Wolf J

Journal: Journal of Thoracic Oncology, Vol 5, No 6, March 2010, doi: 10.1097/JTO.0b013e3181cf32aa
Veröffentlichung: März 2010